CD8+ TEMRA cells were significantly higher in CMV-positive versus CMV-negative cases in both the control and PD group, but the effect was more significant in the controls (p < 0.001) compared to the patients (p = 0.026) (Fig. 2B). This evidence concerns the gene CD8A and Parkinson disease.